Trending
Most Popular
AbbVie’s JUVMO Approval Puts Parkinson’s Innovation Back in Motion And Serina Therapeutics Has a Timely Opening -( $ABBV $AMRX $SER $SUPN $IBB $XBI )
AbbVie Inc. (NYSE: ABBV) has secured (Sept. 28) FDA approval for JUVMO™ (tavapadon), a new once-daily Parkinson’s…
by John F. Heerdink, Jr. 2 days ago
Biotech’s Durability Trade Is Getting Interesting: Kodiak, Eupraxia and Serina Put the Burden of Treatment in Focus -( $ABBV $EPRX $IBB $KOD $SER $XBI )
The biotech market has long rewarded breakthrough efficacy. Increasingly, it is also rewarding something patients and…
by John F. Heerdink, Jr. 2 days ago
Agriculture & Energy
Valar Atomics, NVIDIA and the New AI Infrastructure Trade: Power Is the Prize -( $BA $NVDA )
The next chapter of the artificial-intelligence buildout may be written not only in silicon, but in…
by John F. Heerdink, Jr. 2 days ago
AI Power, Solar IP and California Oil: Why Bloom Energy, First Solar, T1 Energy and Sable Offshore Are Turning Up the Heat -( $BE $CSIQ $FSLR $ORCL $SOC $TE )
The energy market is developing a new hierarchy of importance: dependable power for artificial intelligence, domestic…
by John F. Heerdink, Jr. September 25, 2026
Tennessee’s New Growth Triangle: Dolly’s Mountains, Oracle’s Cloud and Tesla’s Megapacks -( $EPRX $ORCL $TSLA )
Tennessee is increasingly offering investors a compelling three-part growth story: tourism-fueled real estate in Sevier County,…
by John F. Heerdink, Jr. September 23, 2026
Biotech & Healthcare
Eupraxia’s One-and-Done EoE Strategy Gains a 52-Week Tailwind -( $EPRX $IBB $REGN $SNY $XBI )
Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX; TSX: EPRX) has added a potentially important chapter to its eosinophilic esophagitis,…
by John F. Heerdink, Jr. 6 hours ago
Iovance Biotherapeutics Raises 2026 Revenue Guidance as Amtagvi Demand Accelerates & Goldman Resumes Coverage – ( $GS $IOVA $XBI $IBB )
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) delivered the sort of update growth investors prefer: higher guidance, record revenue,…
by John F. Heerdink, Jr. 19 hours ago
AbbVie’s JUVMO Approval Puts Parkinson’s Innovation Back in Motion And Serina Therapeutics Has a Timely Opening -( $ABBV $AMRX $SER $SUPN $IBB $XBI )
AbbVie Inc. (NYSE: ABBV) has secured (Sept. 28) FDA approval for JUVMO™ (tavapadon), a new once-daily Parkinson’s…
by John F. Heerdink, Jr. 2 days ago
Consumer Goods & Trends
What Are The Odds that New York’s Polymarket Lawsuit Could Be a Bullish Turning Point for Regulated Prediction Markets? -( $CZR $COIN $DKNG $HOOD $ICE $MGM )
New York’s lawsuit against Polymarket U.S. is an obvious legal headache, but it may also accelerate…
by John F. Heerdink, Jr. September 24, 2026
From Drive-Thru Screens to Digital Clinics, Data Is Becoming the New Storefront -( $AMWL $AMZN $MCD $SMWB $WMT
McDonald’s Corp. (NYSE: MCD), Similarweb Ltd. (NYSE: SMWB), and Amwell (NYSE: AMWL) are pursuing distinctly different…
by John F. Heerdink, Jr. September 24, 2026
Aurora Innovation Targets 30,000 Driverless Trucks by 2030 as Autonomous Freight Scales -( $AUR $BAC $FDX $KDK $MS $NVDA $PCAR $R $SNDR $TM $TSLA $UBER $VOLVY $WERN )
Aurora Innovation, Inc. (NASDAQ: AUR) is no longer asking investors to imagine a future in which a…
by John F. Heerdink, Jr. September 23, 2026
Financials & Fintech
What Are The Odds that New York’s Polymarket Lawsuit Could Be a Bullish Turning Point for Regulated Prediction Markets? -( $CZR $COIN $DKNG $HOOD $ICE $MGM )
New York’s lawsuit against Polymarket U.S. is an obvious legal headache, but it may also accelerate…
by John F. Heerdink, Jr. September 24, 2026
Thursday’s AI Risk-On Roll Call -( $BTC $CRM $SRWD $EXOD $LPL $NVDA $OKTA )
Wall Street’s optimism Thursday has a broad, increasingly commercial feel: NVIDIA (NASDAQ: NVDA) powering the compute, Salesforce (NYSE: CRM) placing…
by John F. Heerdink, Jr. August 27, 2026
Exodus Movement: The Self-Custody Trade Gets a Public-Market Seat -( $BTC $EXOD )
Exodus Movement, Inc. (NYSE American: EXOD) offers investors an increasingly unusual combination: a publicly traded software company…
by John F. Heerdink, Jr. August 25, 2026
Investing & Inspiration
U.S. Stock Market Today (September 30, 2026): Indexes Finish Mixed as Cooling Inflation Lifts Tech, While Energy and Geopolitics Keep Risk Elevated -( $BA $DOCS $EPRX $LLY $MAT $META $MODD $MU $NVDA $YSG )
NYSE trading floor with screens showing stocks sliding as rising U.S. Treasury yields and Walmart (WMT)…
by John F. Heerdink, Jr. 1 hour ago
Eupraxia’s One-and-Done EoE Strategy Gains a 52-Week Tailwind -( $EPRX $IBB $REGN $SNY $XBI )
Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX; TSX: EPRX) has added a potentially important chapter to its eosinophilic esophagitis,…
by John F. Heerdink, Jr. 6 hours ago
Iovance Biotherapeutics Raises 2026 Revenue Guidance as Amtagvi Demand Accelerates & Goldman Resumes Coverage – ( $GS $IOVA $XBI $IBB )
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) delivered the sort of update growth investors prefer: higher guidance, record revenue,…
by John F. Heerdink, Jr. 19 hours ago
Materials & Natural Resources
Copper’s Next Bull Market May Be Hiding in Plain Sight…Robert Friedland -( $CPER $FCX $GEV $IVN.TO $IVPAF $RIO )
Robert Friedland, the billionaire mining entrepreneur and founder of Ivanhoe Mines (IVN.TO, IVPAF), has framed the…
by John F. Heerdink, Jr. September 4, 2026
Nvidia (NVDA) Earnings and Bitcoin (BTC-USD): AI Chips Meet Digital Gold
The market is presenting investors with an unusually constructive pairing: Nvidia Corp. (NASDAQ: NVDA) continues to…
by John F. Heerdink, Jr. August 24, 2026
The Great Growth Asset Rotation: AI, Orbit and Silver Take Center Stage -( $AMZN ANTH.PVT $ASTS OPAI.PVT $RKLB $SIL $SPCX $T $VZ )
Wall Street has rarely lacked for ambition, but 2026 is offering an especially lavish menu: artificial…
by John F. Heerdink, Jr. August 18, 2026
Technology & Beyond
Valar Atomics, NVIDIA and the New AI Infrastructure Trade: Power Is the Prize -( $BA $NVDA )
The next chapter of the artificial-intelligence buildout may be written not only in silicon, but in…
by John F. Heerdink, Jr. 2 days ago
NVIDIA Brings Safety Rails and a $150 Billion Buyback As The Stock Market Positions For Dense Macro Test This Week -( $CRWV $CSCO $DELL $HPE $IBM $MSFT $NVDA $ORCL $SMCI )
NVIDIA Corp. (NASDAQ: NVDA) seemingly has given many a two-part bullish signal: a record-sized $150 billion increase…
by John F. Heerdink, Jr. 2 days ago
The “Physical AI” Economy: Compute, Energy and Resilience Move to Center Stage During This Weekend’s nor’easter & Beyond -( $AMZN $MSFT $NVDA $ORCL $PSKY $SOC $QCOM )
Wall Street’s latest AI conversation is becoming less about clever chatbots and more about the decidedly…
by John F. Heerdink, Jr. 4 days ago
Latest News
U.S. Stock Market Today (September 30, 2026): Indexes Finish Mixed as Cooling Inflation Lifts Tech, While Energy and Geopolitics Keep Risk Elevated -( $BA $DOCS $EPRX $LLY $MAT $META $MODD $MU $NVDA $YSG )
NYSE trading floor with screens showing stocks sliding as rising U.S. Treasury yields and Walmart (WMT)…
by John F. Heerdink, Jr. 1 hour ago
Cooling Inflation, AI Demand and Consumer Resilience: Why Wall Street’s Bull Case May Be Getting Stronger -( $AAPL $AMZN $CVS $ELV $MCD $NVDA $SKHY $UNH )
A steadier labor market, cooler-than-expected inflation, fresh consumer purchasing power, evolving digital-advertising models and disciplined corporate…
by John F. Heerdink, Jr. 3 hours ago
Eupraxia’s One-and-Done EoE Strategy Gains a 52-Week Tailwind -( $EPRX $IBB $REGN $SNY $XBI )
Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX; TSX: EPRX) has added a potentially important chapter to its eosinophilic esophagitis,…
by John F. Heerdink, Jr. 6 hours ago
Most Read
Featured
U.S. Stock Market Today (September 30, 2026): Indexes Finish Mixed as Cooling Inflation Lifts Tech, While Energy and Geopolitics Keep Risk Elevated -( $BA $DOCS $EPRX $LLY $MAT $META $MODD $MU $NVDA $YSG )
NYSE trading floor with screens showing stocks sliding as rising U.S. Treasury yields and Walmart (WMT)…
by John F. Heerdink, Jr. 1 hour ago
Eupraxia’s One-and-Done EoE Strategy Gains a 52-Week Tailwind -( $EPRX $IBB $REGN $SNY $XBI )
Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX; TSX: EPRX) has added a potentially important chapter to its eosinophilic esophagitis,…
by John F. Heerdink, Jr. 6 hours ago
Amazon’s Amazing Theatrical Expansion – $AMZN $SPY
Amazon has unveiled ambitious plans to significantly increase its theatrical movie releases starting in 2025, aiming…
by John F. Heerdink, Jr. April 3, 2025
Lawrence Summers Warns of Economic Storm Clouds Ahead – $SPY $QQQ $DIA $VIX
Former Treasury Secretary Lawrence Summers has delivered a sobering outlook for the U.S. economy, suggesting that…
by John F. Heerdink, Jr. April 8, 2025

Cooling Inflation, AI Demand and Consumer Resilience: Why Wall Street’s Bull Case May Be Getting Stronger -( $AAPL $AMZN $CVS $ELV $MCD $NVDA $SKHY $UNH )